MDS Virtual Congress 2020 Archives - Page 83 of 149

Loss of CHCHD2 and CHCHD10 disrupts mitochondrial cristae phenocopying patient mutations

D. Narendra, Y. Liu, X. Huang, D. Nguyen, M. Shammas, B. Wu, E. Dombi, D. Springer, J. Poulton, S. Sekine (Bethesda, MD, USA)
Loss of cortical inhibition in Parkinson’s disease

C. Ammann, M. Dileone, C. Pagge, V. Catanzaro, D. Mata-Marín, F. Hernández-Fernández, M.G Monje, A. Sánchez-Ferro, B. Fernández-Rodríguez, C. Gasca-Salas, J.U Máñez-Miró, R. Martínez-Fernández, L. Vela, F. Alonso-Frech, A. Oliviero, J.A Obeso, G. Foffani (Móstoles, Spain)
Loss of Weight Associated with Levodopa / Carbidopa Intestinal Gel

A. Contreras, M. Carrascal, I. Bretón, F. Grandas (Madrid, Spain)
Loss‐of‐function mutations in NR4A2 cause dopa‐responsive dystonia-parkinsonism

T. Wirth, LL. Mariani, G. Bergant, M. Baulac, M.O Habert, N. Drouot, E. Ollivier, A. Hodžic, G.o Rudolf, P. Nitschke, G.a Rudolf, J. Chelly, C. Tranchant, M. Anheim, E. Roze (London, United Kingdom)
Low dose Cabergoline for freezing of gait in advanced Parkinson’s disease – you can have your cake and eat it too!

N. Sharma, A. Kumari, N. Sawal, H. Singh, K. Shukla (Chandigarh, India)
Low Educational Level and Wilson’s disease: A direct path to cognitive decline

J. Lima, F. Rolim, A. Gomes, A. Marinho, V. Mesquita, G. Ferreira, F. Carvalho (Fortaleza, Brazil)
Low Intensity Cycling Combined with Blood Flow Restriction as a Feasible Strategy for Improving Motor Function in Parkinson’s Disease- A Single Case Study

N. Choudhary (Jodhpur, India)
LRRK2 p.G2019S and p.N2081D variants as modifiers of glucocerebrosidase activity

K. Senkevich, E. Yu, L. Krohn, U. Rudakou, J. Ruskey, F. Asayesh, K. Mufti, S. Laurent, D. Spiegelman, S. Fahn, C. Waters, P. Sardi, G. Rouleau, R. Alcalay, Z. Gan-Or (Montreal, QC, Canada)
LSVT LOUD Applied to Adults with Cerebral Palsy: Two Single-Subject Studies

G. Moya-Gale, J. Galgano, C. Ferrone, Y. Chang, G. Tsang, L. Ramig (Brooklyn, NY, USA)
Machine Learning Predicts Clinically Important Improvement in Quality of Life after STN-DBS in Patients with Parkinson’s Disease

E. Rouleau, W. Potters, D. Pina Fuentes, M. Bot, J. Dijk, R. Schuurman, R. de Bie, M. Beudel (Amsterdam, Netherlands)